Meiya Haian Pharmaceutical Co., Ltd.
Meiya Haian Pharmaceutical Co., Ltd., commonly referred to as Meiya Haian, is a prominent player in the pharmaceutical industry, headquartered in China. Established in 2001, the company has made significant strides in the development and manufacturing of high-quality pharmaceutical products, particularly in the fields of oncology and cardiovascular health. With a strong operational presence across Asia and expanding into international markets, Meiya Haian is renowned for its innovative drug formulations and commitment to research and development. The company’s core offerings include a diverse range of generic and proprietary medications, distinguished by their efficacy and safety profiles. Recognised for its robust market position, Meiya Haian has achieved notable milestones, including various certifications and partnerships that underscore its dedication to excellence in healthcare. As a trusted name in pharmaceuticals, Meiya Haian continues to contribute to global health advancements.
DitchCarbon Score
How does Meiya Haian Pharmaceutical Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Meiya Haian Pharmaceutical Co., Ltd.'s score of 0 is lower than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Meiya Haian Pharmaceutical Co., Ltd.'s reported carbon emissions
Meiya Haian Pharmaceutical Co., Ltd., headquartered in China, currently does not have available carbon emissions data for recent years, nor does it specify any reduction targets or initiatives. Without specific emissions figures or commitments, it is challenging to assess the company's climate impact or sustainability efforts. However, the pharmaceutical industry is increasingly focusing on reducing carbon footprints and enhancing environmental responsibility. Companies in this sector are often encouraged to adopt science-based targets and engage in climate pledges to mitigate their environmental impact. As such, Meiya Haian Pharmaceutical may need to establish clear climate commitments and reduction strategies to align with industry standards and expectations.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Meiya Haian Pharmaceutical Co., Ltd. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
